DNA-Based Synthetic Growth Factor Surrogates with Fine-Tuned Agonism*
- PMID: 34142433
- DOI: 10.1002/anie.202105314
DNA-Based Synthetic Growth Factor Surrogates with Fine-Tuned Agonism*
Abstract
Designing synthetic surrogates of functional proteins is an important, albeit challenging, task in the field of chemistry. A strategy toward the design of synthetic agonists for growth factor or cytokine receptors that elicit a desired signal activity has been in high demand, as such ligands hold great promise as safer and more effective therapeutics. In the present study, we used a DNA aptamer as a building block and described the strategy-guided design of a synthetic receptor agonist with fine-tuned agonism. The developed synthetic partial agonist can regulate therapeutically relevant cellular activities by eliciting fine-tuned receptor signaling.
Keywords: aptamers; growth factors; receptors; signal transduction.
© 2021 Wiley-VCH GmbH.
References
-
- X. Wang, P. Lupardus, S. L. LaPorte, K. C. Garcia, Annu. Rev. Immunol. 2009, 27, 29-60.
-
- M. A. Lemmon, J. Schlessinger, Cell 2010, 141, 1117-1134.
-
- M. Atanasova, A. Whitty, Crit. Rev. Biochem. Mol. Biol. 2012, 47, 502-530.
-
- D. J. Riese 2nd, Expert Opin. Drug Discovery 2011, 6, 185-193.
-
- S. Mitra, A. M. Ring, S. Amarnath, J. B. Spangler, P. Li, W. Ju, S. Fischer, J. Oh, R. Spolski, K. Weiskopf, H. Kohrt, J. E. Foley, S. Rajagopalan, E. O. Long, D. H. Fowler, T. A. Waldmann, K. C. Garcia, W. J. Leonard, Immunity 2015, 42, 826-838.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials